Concepedia

Jennifer Bré

JB

Statistics

Publications

3

Citations

54

H-Index

3

Active since

2019

Affiliations

University of St Andrews(Current)

Jennifer Bré is an author at University of St Andrews specializing in oncology, cancer pharmacology, and chemotherapy.

ORCID

Publications per year

2019–2023

3

Publications

3

The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent

Jennifer Bré, Alison L. Dickson, Oliver J. Read et al. · Cancer Chemotherapy and Pharmacology · 2023 · 20 citations · Full text

, , +14

Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031

Awa Sarr, Jennifer Bré, In Hwa Um et al. · Scientific Reports · 2019 · 17 citations · Full text

, , +15

Heparanase-1 is upregulated by hepatitis C virus and favors its replication

Christophe Gallard, Nadjet Lebsir, Hira Khursheed et al. · Journal of Hepatology · 2022 · 17 citations · Full text

, , +11

1–3 of 3